Print

Print


Ray, I'll have a go....
Amanda

Quoting rayilynlee <[log in to unmask]>:

> I tried to get  Dennis Turner to join us.  anyone who wants to try email me 
> for their emails
> 
> Rayilyn Brown
> Director AZNPF
> Arizona Chapter National Parkinson Foundation
> [log in to unmask]
> 
> --------------------------------------------------
> From: <[log in to unmask]>
> Sent: Friday, February 27, 2009 2:33 PM
> To: <[log in to unmask]>
> Subject: Re: Adult Stem Cell Treatment for Parkinson's
> 
> > Any chance of getting Dr. Levesque on the list ?  Both sides could 
> > benefit...
> >
> > Quoting rayilynlee <[log in to unmask]>:
> >
> >> Dr. Levesque
> >>
> >> Thank you again for taking the time to respond to my questions and 
> >> confirm
> >> certain facts about this  case.
> >>
> >> I assure you I never said you claimed a cure or successful treatment for
> >> Dennis Turner, but other people have.  You are to be commended for the
> >> caveats and clarifications in some of the articles. currently on-line.
> >>
> >> I'm afraid most of the public won't read or understand the scientific
> >> publication.
> >>
> >> Again, thank you, you've been most helpful.
> >>
> >> Rayilyn Brown
> >> Director AZNPF
> >> Arizona Chapter National Parkinson Foundation
> >> [log in to unmask]
> >>
> >>
> >> From: Michel Levesque, M.D.
> >> Sent: Saturday, February 21, 2009 12:26 PM
> >> To: rayilynlee
> >> Cc: parkinsn ; [log in to unmask] ; [log in to unmask] ;
> >> Dennis Turner
> >> Subject: RE: Adult Stem Cell Treatment for Parkinson's
> >>
> >>
> >> Dear Ms Lee, I will attempt to briefly answer your additional questions
> >> below.
> >>
> >>
> >>
> >> How can the efficacy of the transplantation be accurately assessed if the
> >> subject still takes PD meds and sometimes has a neurotransmitter turned 
> >> on?
> >> Clinical evaluation is made while "off" medication and "on" medication. 
> >> This
> >> is the standard evaluation for post transplantation patient. In Mr Turner
> >> case, the evaluation was also performed while "off" his thalamic 
> >> stimulator.
> >> Our goal in the future is to stop all medications completely after
> >> transplantation which will allow cells to function better
> >>
> >>
> >>
> >>  Even though as you explain Turner's DBS was not targeted for STN, 
> >> doesn't it
> >> still qualify as a treatment? Mr. Turner was entered in the pilot Phase I
> >> trial after our IRB committee would approve the transplantation only if 
> >> the
> >> initial harvesting was performed during a neurosurgical procedure of
> >> electrode implantation. The upcoming Phase II trial, patients with 
> >> previous
> >> brain surgery or DBS will be excluded from entering the trial.
> >>
> >>
> >>
> >> DBS is now being targeted to areas of the brain to alleviate clinical
> >> depression and epilepsy.  Why does my DBS exclude me from Phase II and
> >> Turner's was a part of his treatment package? See above.
> >>
> >>
> >>
> >> It seems to me that Turner's PD symptoms returned at least five years 
> >> ago.
> >> His head was shaking in the 2004 video of his senate testimony. Why has 
> >> the
> >> peer evaluation taken so long?  Indeed his symptoms returned after 5 
> >> years
> >> post-op. I do not present this as a "cure" and never did. The 
> >> peer-reviewed
> >> paper took years to be submitted because the data and all 
> >> microphotographs
> >> belonged to the previous Celmed company, and they  were reacquired by
> >> NeuroGeneration in 2005. In addition, patent attorneys opposed the
> >> publication until they completed their filing with the USPTO.
> >>
> >>
> >>
> >> The fact that his PD returned is never stated in the publicity 
> >> surrounding
> >> Turner.    What kind of difference would it make if it was? This clearly
> >> stated in our scientific publication.
> >>
> >>
> >>
> >>
> >>
> >> Sincerely yours,
> >>
> >> M.Levesque, MD
> >>
> >>
> >>
> >> ----------------------------------------------------------------------
> >> To sign-off Parkinsn send a message to: 
> >> mailto:[log in to unmask]
> >> In the body of the message put: signoff parkinsn
> >>
> >
> >
> >
> >
> > ----------------------------------------------
> > This mail sent through http://www.ukonline.net
> >
> > ----------------------------------------------------------------------
> > To sign-off Parkinsn send a message to: 
> > mailto:[log in to unmask]
> > In the body of the message put: signoff parkinsn 
> 
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: mailto:[log in to unmask]
> In the body of the message put: signoff parkinsn
> 




----------------------------------------------
This mail sent through http://www.ukonline.net

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn